| Issue |
Section |
Title |
File |
| Vol 92, No 2 (2020) |
Editorial |
Systemic manifestations of inflammatory bowel diseases |
(Rus)
|
| Vol 92, No 2 (2020) |
Consensuns |
Multidisciplinary treatment of the patient with a severe irritable bowel syndrome |
(Rus)
|
| Vol 92, No 2 (2020) |
Original articles |
Bile acids are a risk factor for colorectal cancer |
(Rus)
|
| Vol 92, No 2 (2020) |
Original articles |
Pharmacological and clinical feature of rebamipide: new therapeutic targets |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
Chronic intestinal pseudo-obstruction |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
Resected bowel syndrome: clinical course and treatment options |
(Rus)
|
| Vol 93, No 2 (2021) |
Editorial |
Enteropathy with impaired membrane digestion and the prospects for cytoprotective therapy |
(Rus)
|
| Vol 93, No 2 (2021) |
Original articles |
Screening for celiac disease among patients of the gastroenterological profile |
(Rus)
|
| Vol 93, No 2 (2021) |
Original articles |
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars |
(Rus)
|
| Vol 93, No 2 (2021) |
Reviews |
Clinical value of antibodies in inflammatory bowel diseases |
(Rus)
|
| Vol 93, No 2 (2021) |
History of medicine |
Historical milestones in the knowledge of celiac disease: on the 80th anniversary of the discovery of W.-K. Dike of the аgluten diet |
(Rus)
|
